Dr Michal Sieniawski Dr Brian Angus Professor Stephen Proctor Dr Anne Lennard
| Impact of p53 positive p21 negative phenotype on outcome in CHOP-R treated DLBCL patients | 2014 |
|
Dr Rachel Crossland Dr Michal Sieniawski Dr Brian Angus Professor Stephen Proctor Dr Paul Milne et al. | Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B-cell lymphoma patients | 2013 |
|
Dr Rachel Crossland Dr Michal Sieniawski Dr Brian Angus Dr Susan Proctor Kate McCabe et al. | Mature microRNAs of the miR-17-92 cluster predict for disease outcome in diffuse large B-cell lymphoma (DLBCL) patients treated with CHOP-R immunochemotherapy | 2011 |
|
Professor Mary Slatter Dr Brian Angus Dr Kevin Windebank Professor Sophie Hambleton Dr Mario Abinun et al. | Polymorphous lymphoproliferative disorder with Hodgkin-like features in common gamma-chain-deficient severe combined immunodeficiency | 2011 |
|
Dr Rachel Crossland Dr John Anderson Dr Brian Angus Professor Stephen Proctor Dr Stephen Crosier et al. | A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines | 2010 |
|
Dr Rachel Crossland Professor Stephen Proctor Dr Brian Angus Dr Stephen Crosier Dr John Anderson et al. | A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines | 2010 |
|
Dr Rachel Crossland Dr John Anderson Dr Brian Angus Professor Stephen Proctor Dr Stephen Crosier et al. | A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines | 2010 |
|
Dr John Anderson Lynne Overman Dr Katrina Wood Professor Stephen Proctor Dr Stephen Crosier et al. | Immunophenotyping of diffuse large B-cell lymphoma (DLBCL) defines multiple sub-groups of germinal centre-like tumours displaying different survival characteristics | 2009 |
|
Dr Kevin Windebank Dr Brian Angus Dr Mario Abinun Dr Terence Flood Professor Andrew Cant et al. | Malignancy as a presentation of common gamma chain deficient severe combined immunodeficiency | 2009 |
|
Dr Tryfonia Mainou-Fowler Lynne Overman Dr Katrina Wood Dr Brian Angus Professor Stephen Proctor et al. | A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2 | 2008 |
|
Dr Kevin Windebank Dr Brian Angus Dr Petra Dildey Dr Mario Abinun Dr Terence Flood et al. | Malignancy as a presentation of common gamma chain deficient severe combined immunodeficiency | 2008 |
|
Seamus Kelly Dr John Anderson Dr Brian Angus Dr Christine Challen Professor John Lunec et al. | The predictive value of p53 and p33ING1b in patients with Dukes'C colorectal cancer | 2008 |
|
Dr Tryfonia Mainou-Fowler Lynne Overman Dr Katrina Wood Dr Stephen Crosier Dr Brian Angus et al. | A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2 | 2007 |
|
Dr Brian Angus Dr Patrick Kesteven
| Localized reactive angioendotheliomatosis | 2007 |
|
Dr Penelope Taylor Dr Kevin Windebank Dr Helen Lucraft Dr Katrina Wood Dr Brian Angus et al. | Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents | 2007 |
|
Dr Brian Angus Dr Penelope Taylor
| Impact of tumor EBV status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma | 2006 |
|
Dr Tryfonia Mainou-Fowler Dr Brian Angus Professor Stephen Proctor Dr Penelope Taylor Dr Katrina Wood et al. | Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PdEGF) in classical Hodgkin lymphoma (HL) | 2006 |
|
Dr Penelope Taylor Dr Brian Angus Professor Graham Jackson Dr Helen Lucraft Professor Stephen Proctor et al. | The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial | 2006 |
|
Dr Brian Angus Dr Andrew Carmichael
| A case of Schopf-Schulz-Passarge syndrome | 2005 |
|
Dr Brian Angus Dr Penelope Taylor
| Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study | 2005 |
|
Professor Stephen Proctor Dr Brian Angus Dr Katrina Wood Dr Tryfonia Mainou-Fowler
| Microvessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PDEGF) in classical Hodgkin lymphoma (HL) | 2005 |
|
Professor Andrew Gennery Dr Simon Harris Dr Brian Angus Professor Andrew Cant
| Omenn's syndrome occurring in patients without mutations in recombination activating genes | 2005 |
|
Dr John Anderson Dr Stephen Crosier Lynne Overman Dr Tryfonia Mainou-Fowler Dr Sarah Fordham et al. | Survivin in diffuse large B cell lymphoma: Evaluation as a prognostic marker | 2005 |
|
Dr Brian Angus
| An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD): Evidence for a specific association with EBV+ve HD in young adults | 2003 |
|
Dr John Anderson Dr Stephen Crosier Dr Jyotsna Shrimankar Professor John Lunec Dr Brian Angus et al. | Downregulation of nuclear expression of the p33ING1b inhibitor of growth protein in invasive carcinoma of the breast | 2003 |
|
Dr Brian Angus Dr Clifford Lawrence
| Histopathological assessment of tissue damage caused by electrodesiccation and fulguration | 2003 |
|
Dr Stephen Crosier Dr Katrina Wood Dr Philip Taylor Professor Stephen Proctor Dr Brian Angus et al. | IAP survivin in diffuse large B cell lymphoma: Evaluation as a prognostic marker | 2003 |
|
Dr Brian Angus Dr Gavin Spickett
| Lymphoproliferative disease in antibody deficiency: a multi-centre study | 2003 |
|
Professor Stephen Proctor Professor Graham Jackson Dr Anne Lennard Dr Brian Angus Dr Katrina Wood et al. | Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK) | 2003 |
|
Dr John Anderson Professor John Lunec Dr Brian Angus
| The role of the tumour suppressor p33ING1b in human neoplasia | 2003 |
|
Dr Brian Angus Dr Penelope Taylor
| The Scotland and Newcastle epidemiological study of Hodgkin's disease: Impact of histopathological review and EBV status on incidence estimates | 2003 |
|
Andrew Lodge Dr John Anderson Dr Beate Haugk Dr Brian Angus
| Type 1 growth factor receptor expression in node positive breast cancer: Adverse prognostic significance of c-erbB-4 | 2003 |
|
Professor Muzlifah Haniffa Dr Brian Angus Dr Simon Meggitt
| Warty granuloma faciale | 2003 |
|
Professor Stephen Proctor Dr Brian Angus Professor Graham Jackson Dr Anne Lennard Dr Penelope Taylor et al. | A population-based study of intensive multi-agent chemotherapy with or without autotransplant for the highest risk Hodgkin's disease patients identified by the Scotland and Newcastle Lymphoma Group (SNLG) prognostic index. A Scotland and Newcastle Lymphoma Group study (SNLG HD III) | 2002 |
|
Dr Brian Angus Professor John Lunec Dr Stephen Crosier Andrew Lodge Dr John Anderson et al. | Comparative assessment expression of the inhibitor of growth 1 gene (ING1) in normal and neoplastic tissues | 2002 |
|
Dr Gail Stark Dr Katrina Wood Dr Fergus Jack Dr Brian Angus Professor Stephen Proctor et al. | Hodgkin's disease in the elderly: a population-based study | 2002 |
|
Dr Fergus Jack Dr Brian Angus
| Immunohistochemical detection of CD30 remains negative in nodular lymphocyte-predominant Hodgkin's disease using enhanced antigen retrieval | 2002 |
|
Dr John Anderson Dr Katrina Wood Professor John Lunec Dr Andrew Hall Dr Michael Reid et al. | Loss of nuclear expression of the p33ING1b inhibitor of growth protein in childhood acute lymphoblastic leukaemia | 2002 |
|
Dr John Anderson Dr Marie Mathers Dr Niamh Leonard Dr Stephen Crosier Professor John Lunec et al. | Nuclear to cytoplasmic compartment shift of the p33ING1b tumour suppressor protein is associated with malignancy in melanocytic lesions | 2002 |
|
Seamus Kelly Dr John Anderson Dr Brian Angus Professor John Lunec
| p33/ING1 nuclear expression and TP53 gene mutation in colorectal cancer and their association with clinical outcome | 2002 |
|
Dr John Anderson Dr Stephen Crosier Dr Jyotsna Shrimankar Professor John Lunec Dr Brian Angus et al. | p33ING1b tumour suppressor immunohistochemical expression in invasive breast carcinomas | 2002 |
|
Seamus Kelly Dr John Anderson Dr Brian Angus Professor John Lunec
| TP53 and p33(Ing1) are co-determinants of prognosis in colorectal cancer | 2002 |
|
Dr Stephen Crosier Dr Brian Angus Dr John Anderson
| Use of transgenomic wave and denaturing gel electrophoresis increases the sensitivity of FR3A-FR4 PCR detection of B-cell clonality | 2002 |
|
Dr Brian Angus Professor David Neal Professor John Lunec Kilian Mellon
| Cyclin D1 expression in transitional cell carcinoma of the bladder: Correlation with p53, waf1, pRb and Ki67 | 2001 |
|
Professor John Lunec Seamus Kelly Dr John Anderson Dr Brian Angus
| Expression of p33/ING1 gene products in colorectal cancer and its correlation with survival | 2001 |
|
Dr John Anderson Professor John Lunec Dr Andrew Hall Dr Michael Reid Dr Brian Angus et al. | p33(ING1b) tumour suppresser protein expression in childhood acute lymphoblastic leukaemia by immunohistochemistry | 2001 |
|
Dr Stephen Crosier Dr John Anderson Dr Marie Mathers Dr Niamh Leonard Dr Stephen Crosier et al. | p33(ING1b) tumour suppresser protein expression in melanocytic lesions, an immunohistochemical study of 67 cases | 2001 |
|
Seamus Kelly Professor John Lunec Dr John Anderson Dr Brian Angus
| p33/ING1 nuclear expression in colorectal cancer and its correlation with metastasis and survival | 2001 |
|
Dr John Anderson Dr Stephen Crosier Professor John Lunec Dr Brian Angus
| p33ING1b tumour suppresser protein expression in thyroid lesions determined by immunohistochemistry | 2001 |
|
Dr Marie Mathers Dr Jyotsna Shrimankar Dr David Scott Dr Fraser Charlton Clive Griffith et al. | The use of a standard proforma in breast cancer reporting | 2001 |
|
Dr Claire Bethune Dr Brian Angus Dr Gavin Spickett
| Treatment of EBV driven lymphoproliferation with erythrophagocytosis: 12 year follow up | 2001 |
|
Dr Brian Angus Professor Andrew Cant
| Cytomegalovirus infection in infants with autoimmune lymphoproliferative syndrome (ALPS) | 2000 |
|
Andrew Lodge Dr John Anderson Dr Beate Haugk Dr Brian Angus
| Expression of topoisomerase III alpha in normal and neoplastic tissues determined by immunohistochemistry using a novel monoclonal antibody | 2000 |
|
Andrew Lodge Dr John Anderson Dr Beate Haugk Dr Brian Angus
| Expression of topoisomerase IIIα in normal and neoplastic tissues determined by immunohistochemistry using a novel monoclonal antibody | 2000 |
|
Dr Brian Angus Dr Fergus Jack Professor Graham Jackson Professor Stephen Proctor Dr Penelope Taylor et al. | Improved estimation of tumour burden leads to better prognostic discrimination in classical hodgkin's disease in adults | 2000 |
|
Dr Brian Angus Dr Bridget Wilkins
| Molecular analysis reveals somatically mutated and unmutated clonal and oligoclonal B cells in T-cell-rich B-cell lymphoma | 2000 |
|
Dr Brian Angus Professor John Lunec Dr John Anderson
| Monoclonal antibodies raised to products of the ING1 tumour suppressor gene locus. | 2000 |
|
Andrew Lodge Dr John Anderson Dr Brian Angus
| Pixel-based image cytometry for quantification of nuclear antigen expression using Adobe Photoshop | 2000 |
|
Dr John Anderson Dr Brian Angus Professor John Lunec
| Sequencing of ING1 tumour suppressor gene cDNAs generated from mRNA recovered from normal and neoplastic cell lines. | 2000 |
|
Andrew Lodge Dr John Anderson Dr Beate Haugk Dr Brian Angus
| Type 1 growth factor receptor and topoisomerase expression in breast cancer: Adverse prognostic significance of c-erbB-4 | 2000 |
|
Dr Brian Angus Dr Sathyarathna Gokul Professor Alan Calvert Professor John Lunec
| Bcl-2 expression is a potential prognostic co-factor with P53- mutation status in epithelial ovarian carcinoma | 1999 |
|
Dr Debbie Scott Dr Brian Angus
| Cyclin D1 expression in usual hyperplasia, atypical ductal hyperplasia and low nuclear grade ductal carcinoma in situ of the breast: an immunohistochemical study | 1999 |
|
Dr Ian Brotherick Dr Brian Shenton Dr Brian Angus Jagnohan Varma Professor Frederick Campbell et al. | Cyclin D3 expression, cell proliferation and pathological stage of human primary colorectal cancer | 1999 |
|
Dr Craig Dixon Dr Simon Sinclair Dr Fraser Charlton Dr John Anderson Professor Peter Farr et al. | Diagnosis of mycosis fungoides using histological evaluation, immunophenotyping and molecular analysis in formalin-fixed, parafin-embedded tissue | 1999 |
|
Abid Sattar Professor Steve Robson Dr Brian Angus Professor Frederick Campbell
| Expression of growth regulatory genes in a SCID mouse-human model of intestinal epithelial regeneration | 1999 |
|
Andrew Lodge Dr Andrew Hall Dr Katrina Wood Dr John Anderson Dr Brian Angus et al. | NCL-CD10-270: A new monoclonal antibody recognizing CD10 in paraffin- embedded tissue | 1999 |
|
Dr Fergus Jack Dr Brian Angus Dr Penelope Taylor
| Prognostic score for Hodgkin's disease | 1999 |
|
Dr Fergus Jack Dr Brian Angus
| Signal amplification using biotinylated tyramide for detection of CD 30 and epithelial membrane antigen in nodular lymphocyte predominant Hodgkin's disease | 1999 |
|
Helen Bell Dr Brian Angus
| The value of BCL-6 expression in the differential diagnosis of small B cell lymphoma. | 1999 |
|
Andrew Lodge Dr Andrew Hall Dr John Anderson Dr Michael Reid Dr Brian Angus et al. | A study of the prognostic significance of topoisomerase IIα in childhood acute lymphoblastic Leukaemia | 1998 |
|
Professor Stephen Proctor Dr Penelope Taylor Dr Brian Angus
| A prospective evaluation of the use of a numerical prognostic index for patient management in the context of a population-adjusted clinical epidemiology (PACE) study in the Northern Region, UK | 1998 |
|
Dr Brian Angus Professor David Neal Professor John Lunec Kilian Mellon
| Cyclin Dl expression in TCC of the bladder: Correlation with WAF1, p53 and Ki67 | 1998 |
|
Dr John Anderson Dr William Cowan William Cunliffe Dr Brian Angus
| ER-CARD: a more sensitive method for detection of oestrogen receptor by immunohistochemistry | 1998 |
|
Professor Julie Irving Gerard Cain Dr Brian Angus Dr Penelope Taylor
| The role of alternative splicing of the adhesion molecule, CD44, in lymphoid malignancy | 1998 |
|
Dr John Anderson Professor Thomas Lennard Dr Brian Angus
| A novel quantitative immunoassay system for p53 using antibodies selected for optimum designation of p53 status | 1997 |
|
Professor Graham Jackson Dr Philip Taylor Dr David Goff Dr Anne Lennard Dr Brian Angus et al. | High dose ifosfamide in combination with etoposide and epirubicin in the treatment of relapsed/refactory Hodgkin's disease: A report on toxicity and efficacy. | 1997 |
|
Professor Debra Bevitt Emeritus Professor Geoffrey Toms Professor Thomas Lennard Professor Bruce Westley Dr Brian Angus et al. | New monoclonal antibodies to oestrogen and progesterone receptors effective for paraffin section immunohistochemistry | 1997 |
|
Dr Mark Egan Dr John Anderson Dr William Cowan Dr Brian Angus
| Optimised determination of vascular invasion in breast cancer by immunohistochemistry for CD31: production of a novel monoclonal antibody and comparison with conventional assessment. | 1997 |
|
Professor Nick Reynolds Carole Todd Dr Brian Angus
| Overexpression of protein kinase C-α and -β isozymes by stromal dendritic cells in basal and squamous cell carcinoma | 1997 |
|
Alan Adams Dr Brian Angus Dr Gajanan Sherbet Professor Thomas Lennard
| Prediction of nodal metastasis and prognosis in breast cancer: A neural model | 1997 |
|
Professor Julie Irving Gerard Cain Dr Brian Angus
| The role of alternative splicing of the adhesion molecule, CD44 in lymphoid malignancy | 1997 |
|
Dr John Anderson Dr Brian Angus
| Determination of the clinical significance of cyclin a expression in human breast cancer using a novel monoclonal antibody | 1996 |
|
Professor Julie Irving Gerard Cain Dr Brian Angus
| OCT embedded sections of pathological specimens as a source of high quality RNA for reverse transcriptase/polymerase chain reaction | 1996 |
|
Dr John Anderson Dr Brian Angus Professor Thomas Lennard
| p53 protein as a prognostic indicator in breast carcinoma: A comparison of four antibodies for immunohistochemistry | 1996 |
|
Dr John Anderson Professor Thomas Lennard Dr Brian Angus
| Retinoblastoma protein in human breast carcinoma: Immunohistochemical study using a new monoclonal antibody effective on routinely processed tissues | 1996 |
|
Alan Adams Dr Brian Angus Dr Gajanan Sherbet Professor Thomas Lennard
| The detection of nodal metastasis in breast cancer using neural network techniques | 1996 |
|
Dr Mark Levasseur Dr Peter Middleton Dr Brian Angus Professor Stephen Proctor Jean Norden et al. | c-MYC gene abnormalities in high grade and centroblastic-centrocytic Non-Hodgkins Lymphoma | 1995 |
|
Dr John Anderson Dr Brian Angus Professor Thomas Lennard
| Determination of the prognostic value of cyclin D1 overexpression in breast cancer | 1995 |
|
Dr Ian Brotherick Dr Brian Shenton Dr William Cowan Dr Brian Angus Professor Thomas Lennard et al. | P53 expression measured by flow cytometry: a comparison of 3 monoclonal antibodies and the relationship with grade and DNA ploidy in breast cancer | 1995 |
|
Dr Ian Brotherick Dr Brian Shenton Dr Brian Angus Ian Waite Professor Thomas Lennard et al. | A flow cytometric study of c-erbB-3 expression in breast cancer | 1995 |
|
Dr Ian Brotherick Dr Brian Shenton Dr William Cowan Dr Brian Angus Professor Thomas Lennard et al. | Relationship between flow cytometric and immunohistochemically detected C-ERBB-2 expression, grade and DNA ploidy in breast cancer | 1995 |
|
Dr Anne Lennard Dr Brian Angus Professor Stephen Proctor
| Prognostic Significance of Epstein Barr Virus Association in Hodgkins Disease | 1994 |
|
Professor Graham Jackson Dr Anne Lennard Dr Penelope Taylor Dr Peter Carey Dr Brian Angus et al. | Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission | 1994 |
|
Dr John Anderson Dr Christopher Wright Dr Brian Angus
| NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study | 1994 |
|
Dr Penelope Taylor Professor Graham Jackson Dr Anne Lennard Dr Helen Lucraft Professor Stephen Proctor et al. | Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue | 1993 |
|
Dr Brian Angus Dr Christopher Wright Professor Thomas Lennard Dr Ian Corbett
| Retinoblastoma and P53 gene expression related to relapse and survival in human breast cancer - an immunohistochemical study | 1992 |
|
Dr Felicity May Professor Bruce Westley Dr Brian Angus Professor Thomas Lennard
| Expression of antimetastatic gene NM23 | 1991 |
|
Dr Felicity May Professor Bruce Westley Dr Brian Angus Professor Thomas Lennard
| Expression of the antimetastatic gene NM23 in human breast cancer: an association with good prognosis | 1991 |
|
Professor Thomas Lennard Dr Brian Angus
| P53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study | 1991 |
|
Dr Brian Angus Diana Levett Dr Sarah Johnson Professor Thomas Lennard Dr Felicity May et al. | The prognostic significance of the lysosomal protease cathepsin-D in human breast cancer - an immunohistochemical study | 1991 |
|
Dr Roger Dykins Dr Ian Corbett Dr Christopher Wright Professor Thomas Lennard Dr Brian Angus et al. | Long-term survival in breast cancer related to overexpression of the C-ERBB-1 oncoprotein - an immunohistochemical study using monoclonal antibody NCL-CB11 | 1991 |
|
Dr Brian Angus Professor Bruce Westley Dr Felicity May
| Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study. | 1990 |
|
Dr Christopher Wright Dr Ian Corbett Dr Brian Angus Professor Thomas Lennard
| C-ERBB-2 oncoprotein expression in mammary and extramammary pagets disease - an immunohistochemical study | 1990 |
|
Craig Wright Dr Ian Corbett Professor Thomas Lennard Dr Brian Angus
| C-ERBB-2 Oncoprotein expression in mammary and extramammary pagets disease determined by immunohistochemistry using the novel monoclonal antibody NCL-CB11 | 1990 |
|
Dr Ian Corbett Dr Brian Angus Dr Felicity May Professor Bruce Westley
| NCL-CB11 anto c-erbb-2 monoclonal antibody characterization and correlation with gene amplification | 1990 |
|
Dr Ian Corbett Dr Brian Angus Dr Felicity May Professor Bruce Westley
| NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbb-2 oncogene protein effective for use on formalin fixed, paraffin embedded tissue | 1990 |
|
Dr Felicity May Professor Bruce Westley Dr Brian Angus Professor Thomas Lennard
| The antimetastatic gene NM23: its expression in human breast cancers | 1990 |
|
Dr Ian Corbett Dr Christopher Wright Professor Thomas Lennard Dr Brian Angus
| c-erbB-2 oncoprotein expression related to hitological type in breast cancer: an immunohistochemical study. | 1990 |
|
Dr Brian Angus Dr Andrew Hall Professor Stephen Proctor
| Glutathione S-transferase (placental) as a marker of transformation in the human cervix uteri: an immunohistochemical study | 1990 |
|
Dr Anne Lennard Professor Stephen Proctor Dr Brian Angus Dr Helen Lucraft
| Lomustine, vindesine and bleomycin (LVB) used in the treatment of relapsed advanced Hodgkin's disease: A prospective study on behalf of the east of Scotland and Newcastle lymphoma group (ESNLG) | 1989 |
|
Dr Mary Robinson Dr Brian Angus Professor Stephen Proctor
| Lymphocyte depleted Hodgkins disease: A retrospective immunohistological study | 1987 |
|